Scientific Advisory board
NEURON is the European Research Area network with a holistic view of the brain and a focus on mental health. In accordance to the national policy priorities of many participating funders, mental disorders are of high importance in NEURON call topics. NEURON Cofund2 will continue with this strategy. The activities are based on the Strategic Research Agenda (SRA), developed and written by the NEURON SAB and additional highly renowned experts.
The SRA encompasses the brain as a whole and covers mental disorders, neurological diseases, sensory organ diseases and peripheral nervous system disorders. The scientific priorities laid out in the SRA aim at understanding disease mechanisms (cell-based & animal models, comorbidities, and resilience), understanding disease progression (pathology, diagnosis, biomarkers, stratification) as well as interventions (prevention and treatment).
The Scientific Advisory Board (SAB) is appointed to support the planning of strategic research issues.
Frauke Zipp (Chair Scientific Advisory Board)
Director of the Department of Neurology at the University Medical Center Mainz, Department of Neurology, Mainz, Germany;
Member of the German National Academy of Sciences Leopoldina
Child and Adolescent Department of Psychiatry at Hospital General, Universitario Gregorio Marañón, Madrid, Spain;
past President of The European College of Neuropsychopharmacology (ECNP); President of the Spanish Psychiatry Society
Head of the Biology and Biomedicine Area of the CSIC (Consejo Superior de Investigaciones Cientificas), Madrid, Spain;
Member of the FENS Communication/Publication Committee
Chair in Mental and Neurological Diseases at the Sackler Faculty of Medicine , Tel Aviv, Israel
Director Department of Experimental Neurology; director of the QUEST Center for Transforming Biomedical Research at the Berlin Institute of Health. QUEST (Quality-Ethics- open Science – Translation)
Inserm Research Director and
Head of Institut du Fer à Moulin, Paris, France;
President of the French society for Neuroscience
Nencki Institute, Warsaw, Poland; Chair, Division of Biological Sciences, Polish Academy of Sciences; President of the EMBC (European Molecular Biology Conference);
President of EMBC
Dimitri M Kullmann
UCL Queen Square Institute of Neurology
University of Paris Est, France
Head of Psychiatry (Hôpitaux Universitaires Mondor, Assistance-Publique-Hôpitaux de Paris). “Translational Psychiatry” lab at Inserm. Executive director of a non profit foundation, “Fondation FondaMental”
University of Liège, Vice- Director GIGA-Neurocience Unit, FNRS Research Director
Head of the Department of Neurodegenerative Diseases and Director of the Division of Neurology 5 & Neuropathology at the Neurological Institute “Carlo Besta”, Milan, Italy